Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Change From Baseline to Chronic Kidney Disease Patient Before and After Administration Drug

NCT02378194 is registered in ClinicalTrials.gov with Hyundai Pharmaceutical Co., LTD. as lead sponsor.

NCT NCT02378194
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02378194 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Change From Baseline to Chronic Kidney Disease Patient Before and After Administration Drug
Lead sponsor
Hyundai Pharmaceutical Co., LTD.
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2010
Completion date
March 31, 2013
Enrollment
62 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

chronic renal failure